Mead Johnson Nutrition Co. (NYSE:MJN)

1picks (82.16) Submitted: 2/20/2013 10:53:32 AM : Start Price: $79.34 MJN Score: -1.56

A good long-term defensive holding, maker of Enfamil infant formula. Sales are growing rapidly in the emerging markets as millions of consumers enter the middle class and begin buying infant formula for the first time.

stoney44 (< 20) Submitted: 11/1/2012 5:37:10 PM : Start Price: $63.23 MJN Score: -18.49

MJN has a weak marketing strategy and an innovation pipeline that is storng long trem but less so in 2013

chopchop0 (38.84) Submitted: 10/25/2012 10:31:16 AM : Start Price: $64.10 MJN Score: +14.97

Moaty brand and product

RugbyViking13 (90.47) Submitted: 7/12/2012 9:12:10 PM : Start Price: $76.52 MJN Score: -13.14

Nutricuticals, I believe is the buzz word

perspective03 (< 20) Submitted: 7/3/2011 10:20:51 AM : Start Price: $66.94 MJN Score: -2.57

They will underperform because competition will intensify and therefore Mead will need to increase their marketing efforts, this will increase costs. If they introduce a new formula that will allow a clear brand-differentitaiton, then they will have the opportunty to outperform. If not, then they will need to look to operations to reduce costs or expand to other markets in their goal to maintain their market share.

Pumpstick (99.19) Submitted: 8/12/2010 2:58:25 AM : Start Price: $48.37 MJN Score: -21.02

No!

gartersnk (44.99) Submitted: 12/2/2009 11:42:26 PM : Start Price: $40.29 MJN Score: +61.41

rocket since ipo

TheHague (47.50) Submitted: 7/26/2009 6:12:59 PM : Start Price: $34.66 MJN Score: +73.89

I have been with MJN almost since the beginning. Recently they have begun to pay dividends and appear to be very profitable and growing. Another nice defensive pick to keep the $'s coming in.

hopetrader (90.52) Submitted: 3/8/2009 1:11:11 AM : Start Price: $24.44 MJN Score: +97.99

Babies will keep being born. This is a great company. Once our economic conditions change and they get rid of the debt i see a huge turn around. Could drop down a little below IPO price but it will rise. Im long on this pick two years.

TMFBiologyFool (99.14) Submitted: 2/12/2009 2:31:39 PM : Start Price: $24.96 MJN Score: -132.23

A good move for BMY, but a little overpriced for now even if babies do have to eat during recessions.